Literature DB >> 7773355

Endoscopic injection sclerotherapy for esophageal variceal hemorrhage in myeloproliferative disorder: case report.

M Matsumoto1, H Matsumoto, T Miyake, K Nakao, K Iwata, N Yoshida, K Kanai.   

Abstract

A 70-year-old woman with myeloproliferative disorder and massive splenomegaly presented with hematemesis. Emergency endoscopy demonstrated bleeding from esophageal varices. Management of variceal hemorrhage by endoscopic injection sclerotherapy, using 5% ethanolamine oleate, was successful. Following the control of variceal bleeding, she was treated with hydroxyurea, a myelosuppressive agent. The spleen size markedly decreased and she was discharged 3 months later. Variceal hemorrhage in myeloproliferative disorder has been reported to be fatal on many occasions, despite different therapeutic approaches, including surgery. In this report, we demonstrated that endoscopic injection sclerotherapy followed by treatment with a myelosuppressive agent was effective in a patient with myeloproliferative disorder and variceal hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773355     DOI: 10.1007/bf02348672

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  20 in total

1.  Surgical implications of polycythemia vera.

Authors:  W T FITTS; A ERDE; G W PESKIN; J W FROST
Journal:  Ann Surg       Date:  1960-09       Impact factor: 12.969

2.  Portal hypertension in myeloid metaplasia. Report of a case without apparent portal obstruction.

Authors:  N OISHI; S N SWISHER; J M STORMONT; S I SCHWARTZ
Journal:  Arch Surg       Date:  1960-07

3.  Portal hypertension complicating myelofibrosis: reversal following splenectomy.

Authors:  B E Lukie; R T Card
Journal:  Can Med Assoc J       Date:  1977-10-08       Impact factor: 8.262

4.  Development of large spleno-adreno-renal shunt after endoscopic sclerotherapy.

Authors:  J B Dilawari; G S Raju; Y K Chawla
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

5.  Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia.

Authors:  M N Silverstein; E E Wollaeger; A H Baggenstoss
Journal:  Arch Intern Med       Date:  1973-04

Review 6.  Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia.

Authors:  J Laszlo
Journal:  Semin Hematol       Date:  1975-10       Impact factor: 3.851

7.  Endoscopic sclerotherapy using absolute alcohol.

Authors:  S K Sarin; G K Sachdeva; R Nanda; J C Vij; B S Anand
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

8.  Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy.

Authors:  J Terblanche; H I Yakoob; P C Bornman; G V Stiegmann; R Bane; M Jonker; J Wright; R Kirsch
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

9.  Myeloproliferative disorders.

Authors:  S I Schwartz
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

10.  Myelofibrosis, splenomegaly, and portal hypertension.

Authors:  P Jacobs; S Maze; F Tayob; E P Harries-Jones
Journal:  Acta Haematol       Date:  1985       Impact factor: 2.195

View more
  1 in total

1.  Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding.

Authors:  Xiaoquan Huang; Ming Zhang; Yingjie Ai; Siyu Jiang; Mei Xiao; Lifen Wang; Yourong Jian; Yuzheng Zhuge; Chunqing Zhang; Shiyao Chen
Journal:  Ther Adv Chronic Dis       Date:  2022-09-22       Impact factor: 4.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.